Nivea Maker Beiersdorf Cuts Guidance for 2026, Citing Market Conditions
Beiersdorf trimmed its full-year guidance on Monday on slower-than-expected recovery at its core brand Nivea and other economic headwinds.

PARIS, France — Seaweed may not be the first ingredient that springs to mind for perfume. But algae are among obscure ingredients to which perfume

PARIS, France — Seaweed may not be the first ingredient that springs to mind for perfume. But algae are among obscure ingredients to which perfume

To maintain incentives for the kind of innovation that keeps Europe at the heart of the global fragrance industry, scents should be protected by intellectual property law, argues Kimiya Shams.

To maintain incentives for the kind of innovation that keeps Europe at the heart of the global fragrance industry, scents should be protected by intellectual property law, argues Kimiya Shams.

PARIS, France — Chanel designer Karl Lagerfeld, with his shock of white hair, black glasses and leather gloves, will be the center of attention in

PARIS, France — Chanel designer Karl Lagerfeld, with his shock of white hair, black glasses and leather gloves, will be the center of attention in
ADVERTISEMENT
ADVERTISEMENT
Beiersdorf trimmed its full-year guidance on Monday on slower-than-expected recovery at its core brand Nivea and other economic headwinds.
The refillable clean makeup brand will enter the complexion category as it makes its debut across over 700 Ulta Beauty doors.
The retailer is considering lowering the investment cost for late backers who came in at a valuation of up to $64 billion as it prepares to list at a much lower value, people familiar with the matter said.
As shoppers incorporate weight-loss drugs and more sophisticated skincare into their daily routines, a cottage industry is growing.
The fashion icon, as famous for his singular talent as a scandal that cost him one of the industry’s top jobs, will become one of only three living designers to get a major solo exhibition at the museum.
Abbvie reported second quarter profit and sales that topped expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.
The German sports brand posted a narrower loss in the second quarter as it pushed ahead with an effort to restore growth next year.
DSM-Firmenich beat market expectations for second-quarter core earnings, said full-year sales growth should reach the upper end of its target range on the back of broad-based volume growth.